公共衞生及預防疾病
《預防及控制疾病(使用疫苗)規例》(第599K章)下認可疫苗的審批
2019冠狀病毒病疫苗顧問專家委員會成員名單
(84KB)
(84KB)
Report on Evaluation by Advisory Panel on COVID-19 Vaccines
Brief summary update on COVID-19 Vaccines endorsed by Advisory Panel
- Brief Summary Update on CoronaVac COVID-19 Vaccine (Vero Cell), Inactivated (4 July 2023)
(只備英文版) (135KB) - Brief Summary Update on CoronaVac COVID-19 Vaccine (Vero Cell), Inactivated (15 February 2023)
(只備英文版)(28KB) - Brief Summary Update on CoronaVac COVID-19 Vaccine (Vero Cell), Inactivated (19 September 2022)
(只備英文版)(27KB) - Brief Summary Update on CoronaVac COVID-19 Vaccine (Vero Cell), Inactivated (7 July 2022)
(只備英文版)(144KB) - Brief Summary Update on CoronaVac COVID-19 Vaccine (Vero Cell), Inactivated (14 April 2022)
(只備英文版)(23KB) - Brief Summary Update on CoronaVac COVID-19 Vaccine (Vero Cell), Inactivated (12 January 2022)
(只備英文版)(23KB) - Brief Summary Update on CoronaVac COVID-19 Vaccine (Vero Cell), Inactivated (30 September 2021)
(只備英文版)(72KB) - Brief Summary Update on CoronaVac COVID-19 Vaccine (Vero Cell), Inactivated (2021年7月14日)
(只備英文版)(22KB) - Brief Summary Update on CoronaVac COVID-19 Vaccine (Vero Cell), Inactivated (2021年4月29日)
(只備英文版)(351KB) - Brief Summary Update on COMIRNATY™ COVID-19 mRNA Vaccine (BNT162b2) Concentrate for Dispersion for Injection (4 July 2023)
(只備英文版 (140KB) - Brief Summary Update on COMIRNATY™ COVID-19 mRNA Vaccine (BNT162b2) Concentrate for Dispersion for Injection (15 February 2023)
(只備英文版)(43KB) - Brief Summary Update on COMIRNATY™ COVID-19 mRNA Vaccine (BNT162b2) Concentrate for Dispersion for Injection (19 September 2022)
(只備英文版)(24KB) - Brief Summary Update on COMIRNATY™ COVID-19 mRNA Vaccine (BNT162b2) Concentrate for Dispersion for Injection (7 Jul 2022)
(只備英文版)(144KB) - Brief Summary Update on COMIRNATY™ COVID-19 mRNA Vaccine (BNT162b2) Concentrate for Dispersion for Injection (14 April 2022)
(只備英文版)(23KB) - Brief Summary Update on COMIRNATY™ COVID-19 mRNA Vaccine (BNT162b2) Concentrate for Dispersion for Injection (12 January 2022)
(只備英文版)(23KB) - Brief Summary Update on COMIRNATY™ COVID-19 mRNA Vaccine (BNT162b2) Concentrate for Dispersion for Injection (30 September 2021)
(只備英文版)(23KB) - Brief Summary Update on COMIRNATY™ COVID-19 mRNA Vaccine (BNT162b2) Concentrate for Dispersion for Injection (2021年7月14日)
(只備英文版)(38KB) - Brief Summary Update on COMIRNATY™ COVID-19 mRNA Vaccine (BNT162b2) Concentrate for Dispersion for Injection (2021年4月29日)
(只備英文版)(385KB)
說明書
- COMIRNATY™ COVID-19 mRNA Vaccine (BNT162b2)(只備英文版)(認可於2023年12月21日)
(651KB) - COMIRNATY™ Original/Omicron BA.4-5 COVID-19 mRNA Vaccine (nucleoside modified)(只備英文版)(認可於2023年12月21日)
(661KB) - COMIRNATY™ 3 micrograms/dose COVID-19 mRNA Vaccine (nucleoside modified)(只備英文版)(認可於2023年12月21日)
(162KB) - COMIRNATY™ 10 micrograms/dose COVID-19 mRNA Vaccine (nucleoside modified)(只備英文版)(認可於2023年12月21日)
(810KB) - CoronaVac COVID-19 Vaccine (Vero Cell), Inactivated (只備英文版)(認可於2023年3月2日)
(248KB) - CoronaVac COVID-19 Vaccine (Vero Cell), Inactivated (detailed edition) (詳版)(只備英文版)(認可於2023年3月2日)
(309KB)